Validation of Hematological Indices
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18-80
SponsorPetrovsky National Research Centre of Surgery
About this trial
The hypothesis of the study is that hematological indices (neutrophil to lymphocyte ratio, platelet to lymphocyte ratio and systemic index of inflammation) may be predictors of infectious complications and multiple organ dysfunction in patients after cardiac surgery.
Eligibility criteria
Qualifiers
age from 18 to 80 years
cardiac surgery
operation in the conditions of cardiopulmonary bypass
availability of voluntary informed consent of the patient to participate in the study
Disqualifiers
refusal of the patient from the study
transfer of the patient to another medical institution
Trial design
Treatments tested in this trial
- Determination of the level of the studied biomarkers
Treatment groups
200 Participants
are divided into 2 treatment groupsSponsors and collaborators
Source ClinicalTrials.gov